LAURUS LABS Financial Statement Analysis
|
||
|
The Revenues of LAURUS LABS have increased by 22.39% YoY .
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -79.88 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
LAURUS LABS Last 5 Annual Financial Results
[BOM: 540222|NSE : LAURUSLABS]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹6,041 Cr | ₹4,936 Cr | ₹4,814 Cr | ₹2,832 Cr | ₹22,919 Cr |
| Expenses | ₹4,448 Cr | ₹3,513 Cr | ₹3,263 Cr | ₹2,267 Cr | ₹19,359 Cr |
| Operating Profit (Excl OI) | ₹1,592 Cr | ₹1,422 Cr | ₹1,551 Cr | ₹565 Cr | ₹3,560 Cr |
| Other Income | ₹6.00 Cr | ₹15 Cr | ₹24 Cr | ₹5.92 Cr | ₹162 Cr |
| Interest | ₹165 Cr | ₹102 Cr | ₹68 Cr | ₹90 Cr | ₹882 Cr |
| Depreciation | ₹324 Cr | ₹251 Cr | ₹205 Cr | ₹187 Cr | ₹1,642 Cr |
| Profit Before Tax | ₹1,109 Cr | ₹1,084 Cr | ₹1,301 Cr | ₹294 Cr | ₹1,198 Cr |
| Profit After Tax | ₹797 Cr | ₹832 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr |
| Consolidated Net Profit | ₹785 Cr | ₹828 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr |
| Earnings Per Share (Rs) | ₹2.93 | ₹14.56 | ₹15.40 | ₹18.33 | ₹23.88 |
| PAT Margin (%) | 3.34 | 13.19 | 16.87 | 20.44 | 9.01 |
| ROE(%) | 4.15 | 21.63 | 28.05 | 45.15 | 15.39 |
| ROCE(%) | 6.64 | 22.97 | 25.97 | 39.82 | 14.14 |
| Total Debt/Equity(x) | 0.61 | 0.49 | 0.52 | 0.56 | 0.60 |
Key Financials |
||
| Market Cap | : | ₹ 33,833.0 Cr |
| Revenue (TTM) | : | ₹ 5,273.3 Cr |
| Net Profit(TTM) | : | ₹ 195.9 Cr |
| EPS (TTM) | : | ₹ 3.6 |
| P/E (TTM) | : | 172.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| LAURUS LABS | 11.4% | 9.4% | 41.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 6% | 4% | 9.9% |
| DIVIS LABORATORIES | 4.7% | 0.3% | 52.4% |
| CIPLA | 7% | 3.7% | 7.2% |
| TORRENT PHARMACEUTICALS | 4.1% | 6.4% | 25% |
| DR REDDYS LABORATORIES | 6.3% | 5% | -4.7% |
| MANKIND PHARMA | 11.6% | 17.3% | 8.8% |
| ZYDUS LIFESCIENCES | -1.6% | -5.8% | -14.5% |
| LUPIN | 0.8% | -1.6% | 19.3% |
LAURUS LABS Revenues
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | 22.39 % |
| 5 Yr CAGR | -28.35 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹6,041 Cr | 22.39 | |
| Mar2023 | ₹4,936 Cr | 2.54 | |
| Mar2022 | ₹4,814 Cr | 69.99 | |
| Mar2021 | ₹2,832 Cr | -87.64 | |
| Mar2020 | ₹22,919 Cr | - | |
LAURUS LABS Operating Profit
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | 11.93 % |
| 5 Yr CAGR | -18.22 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,592 Cr | 11.93 | |
| Mar2023 | ₹1,422 Cr | -8.27 | |
| Mar2022 | ₹1,551 Cr | 174.68 | |
| Mar2021 | ₹565 Cr | -84.14 | |
| Mar2020 | ₹3,560 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -8.54 % |
| 5 Yr CAGR | 14.14 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 26.36% | -8.54 | |
| Mar2023 | 28.82% | -10.55 | |
| Mar2022 | 32.22% | 61.58 | |
| Mar2021 | 19.94% | 28.40 | |
| Mar2020 | 15.53% | - | |
LAURUS LABS Profit After Tax
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -5.20 % |
| 5 Yr CAGR | -4.36 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹785 Cr | -5.20 | |
| Mar2023 | ₹828 Cr | -15.87 | |
| Mar2022 | ₹984 Cr | 285.31 | |
| Mar2021 | ₹255 Cr | -72.78 | |
| Mar2020 | ₹938 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -74.68 % |
| 5 Yr CAGR | -21.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 3.34 % | -74.68 | |
| Mar2023 | 13.19 % | -21.81 | |
| Mar2022 | 16.87 % | -17.47 | |
| Mar2021 | 20.44 % | 126.86 | |
| Mar2020 | 9.01 % | - | |
LAURUS LABS Earnings Per Share (EPS)
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -79.88 % |
| 5 Yr CAGR | -40.82 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.93 | -79.88 | |
| Mar2023 | ₹15 | -5.45 | |
| Mar2022 | ₹15 | -15.98 | |
| Mar2021 | ₹18 | -23.24 | |
| Mar2020 | ₹24 | - | |
LAURUS LABS Return on Capital Employed (ROCE)
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -71.09 % |
| 5 Yr CAGR | -17.22 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 6.64% | -71.09 | |
| Mar2023 | 22.97% | -11.55 | |
| Mar2022 | 25.97% | -34.78 | |
| Mar2021 | 39.82% | 181.61 | |
| Mar2020 | 14.14% | - | |
LAURUS LABS Share Price vs Sensex
| Current Share Price | : | ₹627.4 |
| Current MarketCap | : | ₹ 33,833.0 Cr |
| Updated EOD on | : | Apr 17,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 11.4% |
9.4% |
41.8% |
| SENSEX | 5.8% |
6.1% |
4.7% |
LAURUS LABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.5% | 5.3% | 2.7% |
| BSE 250 SMALLCAP INDEX | 6.3% | 8.2% | -0.6% |
| BSE MIDSMALLCAP | 6.1% | 7.7% | 3.1% |
| BSE MOMENTUM INDEX | 6.1% | 7.8% | 0% |
| BSE 400 MIDSMALLCAP INDEX | 5.8% | 7.6% | 2.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 100 | 6.6% | 9.1% | -1% |
| NIFTY SMALLCAP 250 | 6.6% | 8.9% | 0.4% |
| NIFTY SMALLCAP 50 | 6.5% | 8.8% | 3.3% |
| NIFTY 500 EQUAL WEIGHT | 6.3% | 8% | NA |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 6% | 7.7% | NA |
You may also like the below Video Courses
FAQ about LAURUS LABS Financials
How the annual revenues of LAURUS LABS have changed ?
The Revenues of LAURUS LABS have increased by 22.39% YoY .
How the Earnings per Share (EPS) of LAURUS LABS have changed?
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -79.88 % YoY .
Check out Intrinsic Value of Peers of LAURUS LABS
Compare Stock Analytics of Peers of LAURUS LABS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
